Exaptive’s patent-pending software allows for highly interactive data-centric applications to be built in a fraction of the time and for a fraction of the cost of traditional development tools, with the resulting applications providing the ability to easily navigate and extract information from complex data landscapes. The need for this is pronounced in the area of drug R&D where it currently takes $4-$11B and an average of 15 years to create just one new drug. More than $80B is spent annually in this area. It is estimated that leveraging data could reduce costs by over $40B. (Ernst & Young, Forbes, McKinsey). The Exaptive platform, when applied to this problem, allows for streamlining the patient cohort selection process, finding new uses for existing drugs, leveraging diverse data to better understand both the positive and negative events found in clinical trials, and supporting efficient collaboration both within organizations and across organizations to facilitate discovery.